We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Top Ranked Momentum Stocks to Buy for January 30th
Read MoreHide Full Article
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 30th:
AC Immune SA (ACIU - Free Report) : This clinical stage biopharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 66.7% over the last 60 days.
Agilysys, Inc. (AGYS - Free Report) : This developer and marketer of hardware and software products and services to the hospitality industry has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 50% over the last 60 days.
American Express Company (AXP - Free Report) : This provider of charge and credit payment card products as well as travel-related services has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.7% over the last 60 days.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Top Ranked Momentum Stocks to Buy for January 30th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 30th:
AC Immune SA (ACIU - Free Report) : This clinical stage biopharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 66.7% over the last 60 days.
AC Immune SA Price and Consensus
AC Immune SA price-consensus-chart | AC Immune SA Quote
AC Immune's shares gained 8.3% over the last one month compared to S&P 500’s rise of 1.6%. The company possesses a Momentum Score of A.
AC Immune SA Price
AC Immune SA price | AC Immune SA Quote
Agilysys, Inc. (AGYS - Free Report) : This developer and marketer of hardware and software products and services to the hospitality industry has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 50% over the last 60 days.
Agilysys, Inc. Price and Consensus
Agilysys, Inc. price-consensus-chart | Agilysys, Inc. Quote
Agilysys’ shares gained 30% over the last one month. The company possesses a Momentum Score of B.
Agilysys, Inc. Price
Agilysys, Inc. price | Agilysys, Inc. Quote
American Express Company (AXP - Free Report) : This provider of charge and credit payment card products as well as travel-related services has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.7% over the last 60 days.
American Express Company Price and Consensus
American Express Company price-consensus-chart | American Express Company Quote
American Express’ shares gained 4.1% over the last one month. The company possesses a Momentum Score of A.
American Express Company Price
American Express Company price | American Express Company Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>